India has been recording the world’s largest daily coronavirus caseload for a month even as the government pushes to revive a contracting economy
Coronavirus cases in India surge past 35 lakh; recovery rate rises to 76.61%, over 4.14 cr samples tested
It took 110 days for cases to reach one lakh, just 59 days more to go past the 10 lakh mark and by 23 August, India had reported 30 lakh infections
ICMR mulls setting up registry of hospitalised COVID-19 patients to collect data on response treatments
Fifteen institutions of national repute would be the registry sites and would mentor around 100 COVID-19 hospitals where the data would be collected
Mosquitoes cannot spread COVID-19, Kansas State University finds after studying three most common vectors species
Mosquitoes are common vectors of a number of infectious pathogens, but WHO has maintained that COVID-19 is a respiratory disease that spreads through droplets and fomites.
People more likely to contact COVID-19 at home than through outside contact, finds South Korean study
Findings showed just 2 out of 100 people were infected from non-household contacts, with children under 9 years least likely to be the index patient
ICMR and Bharat Biotech are jointly working on the clinical development of Covaxin, which has received approvals for phase-I and phase-II human trials
Maharashtra makes Aadhaar card, positive test, doctor's prescription mandatory to buy COVID-19 drugs
The anti-viral drug remdesivir was cleared for 'restricted emergency use' to treat severe COVID-19 patients last month, causing a spike in demand for the medicine
COVID-19 Immunity: Lancet study suggests herd immunity may not be possible, antibodies found only in 5% of test population in Spain
Herd immunity of importance as for the pandemic to be over, enough people in a community have to develop immunity against the coronavirus either after getting the disease or through vaccination
Mylan's remdesivir to cost Rs 4,800 per 100 mg vial in India, 80% cheaper than price tag in wealthy nations
Gilead priced remdesivir at $2,340 per patient for rich nations and agreed to send nearly all of its supply of the drug to the United States over the next three months
Human trials of Indian COVID-19 vaccine candidates mark ‘beginning of pandemic’s end’, writes Vigyan Parisar scientist
Aiming to launch a COVID-19 vaccine by 15 August, ICMR had written to select medical institutions to expedite clinical trials for the candidate COVAXIN
Day after ICMR's clarification on coronavirus vaccine, IASc calls timeline 'unprecedented and unfeasible'
A day after the ICMR announced that it aims to launch a COVID-19 vaccine by 15 August, it issued a clarification saying the process to expedite trials was in accordance with norms
Maharashtra launches Project Platina, 'world's largest' plasma therapy trial for COVID-19 patients; all you need to know
Initially, Project Platina will supply plasma to 500 serious COVID-19 patients in Maharashtra, and will be gradually scaled up to cater to at least 5,000 serious patients by August
Ramdev and the Coronil claim: Patanjali treading on thin legal ice, but enforcement gaps might let yoga guru get away with COVID 'drug'
Patanjali Ayurved is treading on thin legal ice with regard to the true effect of the drug compared to what is claimed. Considering the widespread adverse impact that could result from reliance upon an ineffective drug during a deadly pandemic, the question also arises as to whether the usual standard of approval of new drugs is sufficient for the present situation or whether a different standard has to be adopted despite the urgent need for a remedy.
Dexamethasone shows promise in treatment of severely ill COVID-19 patients: All you need to know about the steroid drug
The Oxford University announced that dexamethasone, a common steroid drug, has shown promise in the treatment of severely ill COVID-19 patients by improving their survival rate by at least 20 percent
Coronavirus Outbreak: Over 300 healthcare workers at Delhi’s Sir Ganga Ram Hospital, 100 family members test positive, say reports
Over 300 medical workers at Delhi’s Sir Ganga Ram Hospital were tested positive for coronavirus between 7 April and 2 June, News18 reported.